摘要
目的 :探讨不同药物治疗方案对良性前列腺增生症的经济效果。方法 :选择175例良性前列腺增生症患者 ,用4种不同的药物治疗 ,分为A组哈乐 (34例 )、B组舍尼通 (45例 )、C组通尿灵 (46例 )和D组前列欣 (50例 )4组 ;均为口服给药 ,疗程8wk。运用药物经济学的成本 -效果分析方法进行评价。结果 :4种治疗方案的总成本依次为492 80、499 52、526 40、664 16元 ,其总有效率分别为85 3 %、82 2 %、80 4 %、80 0 %。结论
AIM:To evaluate the economic effectiveness of different therapeutic schemes for benign prostatic hypertrophy METHODS:175 patients with benign prostatic hypertrophy were divided into 4 groups:A,B,C and D They received different drugs,A:tamsulosin(34),B:prostat(45),C:tedenan(46) and D:qiangliexin(50) RESULTS:The costs of A,B,C,D schemes were RMB 492 80,499 52,526 40 and 664 16 yuans,respectively,and the effective ratios were 85 3%,82 2%,80 4% and 80 0%,respectively CONCLUSION:According to the evaluation with pharmacoeconomic cost-effectiveness analysis,A is the best scheme
出处
《中国药房》
CAS
CSCD
2001年第7期410-411,共2页
China Pharmacy
关键词
成本-效果分析
良性前列腺增生症
药物经济学
cost-effectiveness analysis
benign prostatic hypertrophy
pharmacoeconomics
